Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
Janine M. DeBlasi, Aimee Falzone, Samantha Caldwell, et al.
Cancer Research (2023) Vol. 83, Iss. 12, pp. 1953-1967
Open Access | Times Cited: 20

Showing 20 citing articles:

Regulation of antioxidants in cancer
Fábio Hecht, Marco Zocchi, Fatemeh Alimohammadi, et al.
Molecular Cell (2023) Vol. 84, Iss. 1, pp. 23-33
Open Access | Times Cited: 44
A scientometrics and visualization analysis of oxidative stress modulator Nrf2 in cancer profiles its characteristics and reveals its association with immune response
Song‐Bin Guo, Sheng Du, Ke-Yu Cai, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17075-e17075
Open Access | Times Cited: 28
Reductive stress in cancer: coming out of the shadows
Maolin Ge, Thales Papagiannakopoulos, Liron Bar‐Peled
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 103-112
Closed Access | Times Cited: 23
Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
Sang Jun Yoon, Joseph A. Combs, Aimee Falzone, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1426-1442
Open Access | Times Cited: 21
Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function
Jun Takahashi, Takafumi Suzuki, Miu Sato, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114104-114104
Open Access | Times Cited: 7
NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma
Samera H. Hamad, Rani S. Sellers, Nathan Wamsley, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 487-495
Open Access | Times Cited: 4
Pyrimethamine and a potent analogue WCDD115 inhibit NRF2 by suppressing DHFR and one-carbon metabolism
Julius Chembo, Brittany M. Bowman, Kyle M. LaPak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer
Luke Izzo, Tony Reyes, Srijan Meesala, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting mitochondrial ribosomal protein expression by andrographolide and melatonin for colon cancer treatment.
Advaitha Midde, Navpreet Arri, Tibor Kristián, et al.
Cancer Letters (2025), pp. 217647-217647
Closed Access
NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation
Cheng Li, Gang Liang, Ke Yan, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 698, pp. 149536-149536
Closed Access | Times Cited: 3
Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
John G. Witherspoon, Jonathan R. Hall, Dereje D. Jima, et al.
Redox Biology (2024) Vol. 75, pp. 103261-103261
Open Access | Times Cited: 2
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography
Hannah E. Greenwood, Abigail R. Barber, Richard Edwards, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Proximity proteomic analysis of the NRF family reveals the Parkinson’s disease protein ZNF746/PARIS as a co-complexed repressor of NRF2
Kyle M. LaPak, Soma Saeidi, Ilah Bok, et al.
Science Signaling (2023) Vol. 16, Iss. 815
Open Access | Times Cited: 5
Stress response regulation of mRNA translation: Implications for antioxidant enzyme expression in cancer
Yeon Kim, Scot R. Kimball, Elena Piskounova, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 46
Open Access | Times Cited: 1
Effect fraction of Bletilla striata (Thunb.) Reichb.f. alleviates LPS-induced acute lung injury by inhibiting p47 /NOX2 and promoting the Nrf2/HO-1 signaling pathway
Fusheng Jiang, Chenglong Hua, Jieli Pan, et al.
Phytomedicine (2023) Vol. 126, pp. 155186-155186
Closed Access | Times Cited: 2
Nrf2 orchestrates epigenetic regulations and serves as the master regulator of KLF4 expression and activity during arsenic-induced transformation
Ziwei Wang, Zhuoyue Bi, Jessica Bamrah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Kelch-like ECH-associated Protein 1/Nuclear Factor Erythroid 2-related Factor 2 Pathway and Its Interplay with Oncogenes in Lung Tumorigenesis
Taegeun Bae, Mi‐Kyoung Kwak
Journal of Cancer Prevention (2024) Vol. 29, Iss. 4, pp. 89-98
Open Access
Glucose-6-phosphate dehydrogenase deficiency accelerates pancreatic acinar-to-ductal metaplasia
Megan D. Radyk, Barbara Scott Nelson, Christopher J. Halbrook, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
<i>Withaferin</i> A: The Potent Anti-Cancer Agent from Ashwagandha
Deeksha Pal, Dharambir Kashyap, Aman Sharma, et al.
(2023)
Closed Access
Page 1

Scroll to top